Veraflo is a novel integrated wound therapy system providing negative pressure therapy with installation option. It combines the benefit of negative pressure treatment such as V.A.C. therapy with automated solution distribution and removal. It cleanses wound with topical installation, treats infection with topical antimicrobial and prepares wound for primary or secondary closure with negative pressure therapy.
A 54 year old female with initial meningococcal septicaemia, ischaemic colitis and multi-organ failure including dry gangrene of her left hand at mid-metacarpal level had subsequent groin flap reconstruction of her left hand. Her donor site was colonised by multi-resistant pseudomonas refractory to systemic therapy. She had Veraflo therapy with acetic acid soaks between negative pressure therapy and her wound cleaned up with subsequent successful skin grafting and uneventful recovery.
A 48 year old female with background of morbid obesity, Type II DM and rheumatoid arthitis was admitted with cellulitis and skin necrosis of her Left ankle after a mechanical fall, needing multiple debridments. The wound grew Staphylococcus aureus and while being on systemic therapy she was commenced on Veraflow with regular prontosan soaking of the wound as well as negative pressure therapy. After a week of this therapy her wound had granulated and the clean bed was ready for skin grafting with uneventful recovery.
This presentation will demonstrate the advantage of use of Veraflo for cleansing wounds as well as using topical antimicrobial therapy for chemically debriding infected wounds while helping the formation of granulation tissue as a novel alternative for negative pressure therapy (e.g. V.A.C.) alone in treatment of chronically infected wounds, as evidenced in the Canberra Hospital.